Streetbeat News

Products Services

ARGX

JNJ

UCBJF

Johnson & Johnson has submitted a Biologics License Application to the FDA for nipocalimab, a drug for generalized myasthenia gravis (gMG). This marks the first FDA submission for nipocalimab, which showed positive results in a Phase 3 study. The drug will compete with UCB's Rystiggo and Argenx's Vyvgart in the gMG market.

Portfolio Pulse from Vandana Singh

August 29, 2024 | 4:29 pm

UTME

UTime Ltd is addressing recent share price volatility by initiating an internal investigation to check for information leaks or other factors. The company may also start a short-selling investigation. UTime has entered the medical industry, collaborating with Dr. Ehud Baron and planning to acquire a lab for monkeypox vaccine development.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 4:16 pm

XPEV

XPeng shares rise as the company plans a European manufacturing site to mitigate import tariffs and launches a $20,000 vehicle with self-driving features.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 4:10 pm

HAIL

PSNY

Polestar Automotive Holding (NASDAQ:PSNY) shares surged after reporting a significant increase in Q2 deliveries, with a notable 82% rise quarter-over-quarter. The company also announced effective inventory management and a new CEO appointment. Polestar is optimistic about stronger sales in the second half of the year, particularly with the launch of new SUVs.

Portfolio Pulse from Lekha Gupta

August 29, 2024 | 4:09 pm

GANX

Gain Therapeutics, Inc. (NASDAQ:GANX) reported Phase 1 study results for its Parkinson's treatment, GT-02287, showing safety and tolerability. Despite positive data, GANX stock fell 13.40% to $1.16.

Portfolio Pulse from Vandana Singh

August 29, 2024 | 4:05 pm

BNTX

MRK

MRNA

Moderna and BioNTech are focusing on personalized cancer vaccines using mRNA technology to counteract declining COVID-19 vaccine sales. Despite promising developments, high costs and production challenges raise concerns about scalability and affordability.

Portfolio Pulse from Vandana Singh

August 29, 2024 | 4:01 pm

ARKB

BTC

ETHA

ETHE

FETH

GBTC

Bitcoin has surged to $61,000, with experts analyzing pre-election patterns and ETF flows. Ethereum also saw gains, with notable inflows into Ethereum spot ETFs. In contrast, Bitcoin spot ETFs experienced significant outflows. Analysts highlight historical election-related price patterns for Bitcoin.

Portfolio Pulse from Murtuza Merchant

August 29, 2024 | 4:01 pm

FEMY

Femasys shares rose following the announcement that its FemVue MINI fallopian tube assessment solution received CE Mark and Health Canada approval.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 3:57 pm

GANX

Gain Therapeutics shares are trading lower despite announcing positive results from their Phase 1 study of GT-02287, which evaluated its safety, tolerability, and pharmacokinetics.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 3:53 pm

HOOD

Robinhood has integrated Solana into its Web3 wallet, expanding its cryptocurrency offerings. This move is part of Robinhood's broader strategy to strengthen its presence in the digital asset market, following acquisitions like Bitstamp and Pluto Capital. The expansion comes amid increased regulatory scrutiny.

Portfolio Pulse from Murtuza Merchant

August 29, 2024 | 3:48 pm